Patent Application
20080102141
1. Field of the Invention
The invention lies in the field of means and methods to improve/promote fertility of mammals and humans both in male and female.
2. Prior Art
Many means are known to improve/promote fertility of mammals and humans. For example from US 2005/0,287,228 a method of promoting fertility health in women comprising taking a dietary supplement of L-arginine, magnesium, green tea, vitamin E, Vitex agnus-castus, iron, zinc, selenium, vitamins B6 and B12 and folic acid, and a supplement for promoting women's fertility comprising an herb for enhancing hormone balance, increasing progesterone release and ovulation frequency and an amino acid for stimulating reproductive organs by improving circulation is known.
An objective of the invention is to provide a means to improve fertility of mammals and humans both in male and female. In the present invention this objective is realised by using a phytotherapeutic composition comprising extracts of Allium sativum, Juglans regia, Echinacea purpurea and Viola tricolor.
It is noted that from the international application published under No. WO 01/034170 a phytotherapeutic composition is known to improve the condition of the immune system of a human or animal. It has been found that this phytotherapeutic composition has also a positive side effect on fertility of mammals and humans both male and female. In female, egg production went up as abnormalities in cycles disappeared and in male animals semen density, sperm cell count, morphology and motility all showed positive improvements. Embodiments of the use of this composition are described in the claims.
The active ingredients in herbs are often obtained by extraction from the herbs. The extracts are often administered dissolved in or mixed with water via oral ingestion.
The invention further relates to a method for improving and/or promoting fertility health in mammals and humans comprising taking a phytotherapeutic composition comprising extracts of Allium Sativum, Juglans Regia, Echinacea Purpurea and Viola Tricolor. Embodiments of this method are described in the claims
The invention also relates to a phytotherapeutic composition for improving and/or promoting fertility health in mammals and humans comprising 5-7 volume % Allium Sativum extract, 16-18 volume % Eleutherococcus Senticosus extract, 10-12 volume % Juglans Regia extract, 16-18 volume % Echinacea Purpurea extract, 16-18 volume % Viola Tricolor extract, 21-23 volume % Uncaria Tomentosa extract, and 10-12 volume % Carduus Marianus extract.
Preferably the phytotherapeutic composition according to the invention comprises 5.55 volume % Allium Sativum extract, 16.67 volume % Eleutherococcus Senticosus extract, 11.11 volume % Juglans Regia extract, 16.67 volume % Echinacea Purpurea extract, 16.67 volume % Viola Tricolor extract, 22.22 volume % Uncaria Tomentosa extract, and 11.11 volume % Carduus Marianus extract.
In one embodiment, a phytotherapeutic composition comprises a combination of extracts of the herbs Allium Sativum or garlic, Juglans Regia or walnut, Echinacea Purpurea or purple coneflower, Viola Tricolor or Violet, Carduus Marianus or milk thistle, Uncaria Tomentosa or Cat's claw and Eleutherococcus Senticosus or Siberian Ginseng, in the ratio of about 1:2:3:3:2:4:3.
The phytotherapeutic composition preferably comprises at least about 5.55 volume % Allium Sativum extract, 16.67 volume % Eleutherococcus Senticosus extract, 11.11 volume % Juglans Regia extract, 16.67 volume % Echinacea Purpurea extract, 16.67 volume % Viola Tricolor extract, 22.22 volume % Uncaria Tomentosa extract, and 11.11 volume % Carduus Marianus extract. This composition has proven to have a very positive effect on fertility improvement in female and semen improvement in male.
The extracts are obtained in a manner known to experts by extracting the herbs, for example on a water or alcohol basis. Preferably the phytotherapeutic composition is comprised of alcohol extracts of the above-mentioned herbs with an alcohol content of approximately 40%.
In addition to the above-mentioned herbs, the phytotherapeutic composition can also contain other components, such as for example scents and flavours if the medication is administered orally.
Although in the above the invention is explained on the basis of the description of one embodiment, it should be noted that the invention is in no way limited to this embodiment. The invention also extends to all embodiments deviating from this embodiment within the context defined by the claims. For example extraction can also take place on a watery acid basis.
